REVIEW   

Minerva Pediatrica 2018 October;70(5):476-87

DOI: 10.23736/S0026-4946.18.05346-X

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Diagnosis and treatment of Helicobacter pylori in the pediatric population

Fabio CISARÒ, Antonio PIZZOL ✉, Michele PINON, Pier Luigi CALVO

Unit of Pediatric Gastroenterology, Department of Pediatrics, Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy

Although about 35 years have elapsed since the discovery of the Helicobacter pylori, its diagnosis and the choice of optimal eradication therapy are still to be defined. Over time, there has been an increase in interest, publications, recommendations and guidelines. Moreover, management of the disease in pediatric subjects differs somewhat to that of adults and requires a more delicate approach leading to alternative strategies for both diagnosis and treatment. Which patient should be investigated for H. pylori, when to perform noninvasive or invasive tests, what are the proper therapeutic options and best antibiotics regimen to eradicate the infection are practices changing with evidences through time. Therefore, an updated guideline was published by the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) in 2017. The aim of this review is to highlight what is new and what differs between adult and pediatric population regarding the management of H. pylori infection after the ESPGHAN/NASPGHAN guidelines, enriched with updates from literature reviews published over the last two years.

KEY WORDS: Helicobacter pylori - Child - Therapeutics - Proton-pump inhibitors - Breath tests - Infection